EE79 A Cost of Control Analysis of Once-Weekly Subcutaneous Semaglutide Versus Dulaglutide for Bringing Patients to Treatment Targets in China

Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.333
https://www.valueinhealthjournal.com/article/S1098-3015(22)00534-4/fulltext
Title : EE79 A Cost of Control Analysis of Once-Weekly Subcutaneous Semaglutide Versus Dulaglutide for Bringing Patients to Treatment Targets in China
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00534-4&doi=10.1016/j.jval.2022.04.333
First page :
Section Title :
Open access? : No
Section Order : 10290
Categories :
Tags :
Regions :
ViH Article Tags :